查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701310

臨床試驗用品市場規模、佔有率、趨勢分析報告：按臨床階段、產品/服務、最終用途、治療領域、地區、細分預測，2025-2030 年

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End Use, By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗用品市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球臨床試驗用品市場規模預計到2030年將達到41億美元，預計2025年至2030年期間的複合年成長率為7.19%。

臨床試驗數量的增加和試驗進行的複雜性的增加是推動市場成長的主要因素。

在全球範圍內，慢性病盛行率的上升和人口老化的快速發展預計將推動生技藥品研發的成長，進一步推動對高效臨床用品的需求，並促進臨床試驗用品行業的成長。此外，對孤兒藥的需求不斷成長以及對罕見疾病研發的高投入預計也將有助於生物製藥的發展。由於這些因素，該領域在預測期內可能會顯著成長。

例如，2022年，諾華在研發方面投資約100億美元。該公司還在歐盟、日本、中國和美國獲得了23項新藥和罕見疾病藥物的核准。此外，該公司在印度擁有 17 個臨床項目和 44 個正在進行的 III 期項目，針對非典型溶血性尿毒症綜合症 (aHUS)、免疫性血小板缺乏紫斑症(ITP)、脊髓性肌肉萎縮症 (SMA) 和狼瘡性腎炎等罕見疾病。

直接面向患者（DTP）預計將成為未來臨床試驗藥物的分銷模式。 DTP是一種將藥物直接送到患者手中，並進行以患者為中心的臨床實驗的新興模式。這將減少訪問臨床實驗地點的次數並減輕參與者的負擔。 COVID-19 疫情促使人們更多地採用此類模型，以盡量減少干擾，並繼續進行臨床試驗研究。此外，患者保留率和全球多樣化的患者群是該模式採用率高的一些顯著原因。

臨床試驗用品市場報告重點

  • 根據臨床階段，預計市場將以 III 期試驗為主導，佔 2024 年收入佔有率的 53.03%。目前處於 III 期試驗的分子數量眾多是導致這種下降的主要原因。
  • 在服務中，預計儲存和配送部門成長最快，預測期內複合年成長率為 7.54%。全球生技藥品管道的不斷成長以及溫度敏感藥物的增加預計將增加臨床試驗藥物物流的複雜性。
  • 由於遺傳學和生物技術研究的不斷增加，例如基於奈米顆粒的藥物輸送系統的開發，預計生技藥品在預測期內將以 7.48% 的最快複合年成長率成長。
  • 在治療應用方面，腫瘤學佔據市場主導地位，2024 年的收入佔有率為 39.59%。根據合眾國際社報道，由於管理不當，美國醫院浪費了數十億管瓶抗癌藥，凸顯了適當的供應管理的必要性。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章臨床試驗用品市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術進步
    • 人工智慧與數位科技的融合
  • 定價模式分析
  • 2024年臨床試驗量分析
    • 各地區臨床試驗總數（2024年）
    • 各階段臨床試驗總數（2024 年）
    • 依研究設計分類的臨床試驗總數（2024 年）
    • 按主要治療領域分類的臨床試驗總數（2024 年）
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第4章：臨床試驗用品市場：依臨床階段的估計與趨勢分析

  • 臨床試驗用品市場（依臨床階段）：細分儀表板
  • 臨床試驗用品市場（依臨床階段）：波動分析
  • 依臨床階段分類，2018-2030 年
  • 第一階段
  • 第二階段
  • 第三階段
  • 其他

第5章：臨床試驗用品市場：依產品和服務的估計和趨勢分析

  • 臨床試驗用品市場（按產品/服務）：細分儀表板
  • 臨床試驗用品市場（按產品/服務）：變化分析
  • 按產品/服務，2018-2030 年
  • 製造業
    • 2018-2030年臨床試驗供應製造市場估計與細分預測
    • 儲存和運輸
    • 供應鏈管理

第6章臨床試驗用品市場：按治療領域分類的估計和趨勢

  • 臨床試驗用品市場（按治療領域）：細分儀表板
  • 按治療領域分類的臨床試驗用品市場：變化分析
  • 依治療領域，2018-2030年
  • 腫瘤學
  • 中樞神經系統疾病
  • 心血管疾病
  • 感染疾病
  • 代謝紊亂
  • 其他

第7章臨床試驗用品市場：依最終用途的估計和趨勢分析

  • 臨床試驗用品市場（依最終用途）：細分儀表板
  • 臨床試驗用品市場（依最終用途分類）：變化分析
  • 按應用，2018-2030 年
  • 製藥
  • 生物製藥
  • 醫療設備
  • 其他

第 8 章：臨床試驗用品市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章競爭格局

  • 公司分類
    • 市場領導
    • 新興企業
  • 公司簡介
    • Almac Group
    • Biocair
    • Catalent, Inc.
    • KLIFO
    • Movianto
    • PCI Pharma Services
    • Sharp Services, LLC
    • Thermo Fisher Scientific, Inc.
    • UPS Healthcare
    • Paraxel International Corporation
Product Code: GVR-1-68038-514-4

Clinical Trial Supplies Market Growth & Trends:

The global clinical trial supplies market size is estimated to reach USD 4.10 billion in 2030 and is anticipated to grow at a compound annual growth rate CAGR of 7.19% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

Clinical Trial Supplies Market Report Highlights:

  • Based on the clinical phase, the market is anticipated to be dominated by the Phase III trial segment with a 53.03% revenue share in 2024. The presence of a large number of molecules currently under Phase III makes it the primary factor responsible for this deduction
  • Among services, the storage, and distribution segment is anticipated to witness the fastest growth at a CAGR of 7.54% during the forecast period. The rise in global biologics pipeline and temperature-sensitive drugs is expected to increase the complexities related to the logistics of clinical trial supplies
  • Biologics are expected to witness the fastest growth at 7.48% CAGR during the forecast period owing to the increasing research in the field of genetics and biotechnology such as the development of nanoparticle-based drug delivery systems
  • In terms of therapeutic use, oncology dominated the market with a revenue share of 39.59% in 2024. According to the United Press International, hospitals in the U.S. are disposing of billions of cancer drug vials due to improper dosage, thereby indicating the need for appropriate supply management

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regulatory Framework

Chapter 3. Clinical Trial Supplies Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Expansion of Clinical Trials Sites
      • 3.2.1.2. Growing R&D in Biologics and Biosimilars
      • 3.2.1.3. Advancements in Supply Chain Technology
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Presence of Stringent Regulatory Policies
      • 3.2.2.2. High Possibility of Counterfeiting Drugs
  • 3.3. Technological Advancements
    • 3.3.1. Integration of AI and Digital Technologies
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trials Volume Analysis, 2024
    • 3.5.1. Total Number of Clinical Trials, by Region (2024)
    • 3.5.2. Total Number of Clinical Trials, by Phase (2024)
    • 3.5.3. Total Number of Clinical Trials, by Study Design (2024)
    • 3.5.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis

  • 4.1. Clinical Trial Supplies Market, By Clinical Phase: Segment Dashboard
  • 4.2. Clinical Trial Supplies Market, By Clinical Phase: Movement Analysis
  • 4.3. Clinical Trial Supplies Market Estimates & Forecasts, By Clinical Phase, 2018 - 2030 (USD Million)
  • 4.4. Phase I
    • 4.4.1. Phase I Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Phase II
    • 4.5.1. Phase II Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis

  • 5.1. Clinical Trial Supplies Market, By Product & Service: Segment Dashboard
  • 5.2. Clinical Trial Supplies Market, By Product & Service: Movement Analysis
  • 5.3. Clinical Trial Supplies Market Estimates & Forecasts, By Product & Service, 2018 - 2030 (USD Million)
  • 5.4. Manufacturing
    • 5.4.1. Manufacturing Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Storage & Distribution
      • 5.4.2.1. Downstream processing Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
      • 5.4.2.2. Cold Chain Distribution
        • 5.4.2.2.1. Cold Chain Distribution Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
      • 5.4.2.3. Non-Cold Chain Distribution
        • 5.4.2.3.1. Non-Cold Chain Distribution Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Supply Chain Management
      • 5.4.3.1. Supply Chain Management Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Clinical Trial Supplies Market, By Therapeutic Area: Segment Dashboard
  • 6.2. Clinical Trial Supplies Market, By Therapeutic Area: Movement Analysis
  • 6.3. Clinical Trial Supplies Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.5. CNS Diseases
    • 6.5.1. CNS Diseases Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiovascular Diseases
    • 6.6.1. Cardiovascular Diseases Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Infectious Disease
    • 6.7.1. Infectious Disease Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Metabolic Disorders
    • 6.8.1. Metabolic Disorders Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Clinical Trial Supplies Market: End Use Estimates & Trend Analysis

  • 7.1. Clinical Trial Supplies Market, By End Use: Segment Dashboard
  • 7.2. Clinical Trial Supplies Market, By End Use: Movement Analysis
  • 7.3. Clinical Trial Supplies Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Pharmaceutical
    • 7.4.1. Pharmaceutical Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Biologics
    • 7.5.1. Oncology Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Medical Devices
    • 7.6.1. Medical Devices Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Clinical Trial Supplies Market Estimates and Segment Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. North America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. China Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Japan
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Japan Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Thailand Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Company Profiles
    • 9.2.1. Almac Group
      • 9.2.1.1. Participant's Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Service Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Biocair
      • 9.2.2.1. Participant's Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Service Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Catalent, Inc.
      • 9.2.3.1. Participant's Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Service Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. KLIFO
      • 9.2.4.1. Participant's Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Service Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Movianto
      • 9.2.5.1. Participant's Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Service Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. PCI Pharma Services
      • 9.2.6.1. Participant's Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Service Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Sharp Services, LLC
      • 9.2.7.1. Participant's Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Service Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Thermo Fisher Scientific, Inc.
      • 9.2.8.1. Participant's Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Service Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. UPS Healthcare
      • 9.2.9.1. Participant's Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Service Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Paraxel International Corporation
      • 9.2.10.1. Participant's Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Service Benchmarking
      • 9.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Clinical Trials Supplies Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 11 North America Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 12 North America Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 14 U.S. Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 15 U.S. Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 16 U.S. Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 18 Canada Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 19 Canada Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 20 Canada Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 22 Mexico Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 23 Mexico Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 24 Mexico Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 27 Europe Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 28 Europe Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 29 Europe Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 31 Germany Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 32 Germany Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 33 Germany Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 UK Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 35 UK Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 36 UK Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 37 UK Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 39 France Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 40 France Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 41 France Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 43 Italy Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 44 Italy Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 45 Italy Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 47 Spain Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 48 Spain Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 49 Spain Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 51 Denmark Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 52 Denmark Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 53 Denmark Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 55 Sweden Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 56 Sweden Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 57 Sweden Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Norway Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 59 Norway Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 60 Norway Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 61 Norway Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 China Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 68 China Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 69 China Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 70 China Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Japan Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 72 Japan Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 73 Japan Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 74 Japan Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 India Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 76 India Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 77 India Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 78 India Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 South Korea Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 80 South Korea Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 81 South Korea Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 82 South Korea Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83 Australia Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 84 Australia Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 85 Australia Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 86 Australia Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 88 Thailand Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 89 Thailand Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 90 Thailand Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 93 Latin America Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 94 Latin America Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 95 Latin America Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 97 Brazil Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 98 Brazil Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 99 Brazil Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 101 Argentina Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 102 Argentina Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 103 Argentina Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Clinical Trials Supplies Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 110 South Africa Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 111 South Africa Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 112 South Africa Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 117 UAE Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 118 UAE Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 119 UAE Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 120 UAE Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Clinical Trials Supplies Market, by Clinical Phase, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Clinical Trials Supplies Market, by Product & Service, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Clinical Trials Supplies Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Clinical Trials Supplies Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Supplies, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Clinical Trial Supplies, for Phase I, 2018 - 2030 (USD Million)
  • Fig. 13 Global Clinical Trial Supplies, for Phase II, 2018 - 2030 (USD Million)
  • Fig. 14 Global Clinical Trial Supplies, for Phase III, 2018 - 2030 (USD Million)
  • Fig. 15 Global Clinical Trial Supplies, for Others, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Supplies, for Manufacturing, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Supplies, for Cold Chain Distribution, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Supplies, for Non-cold Chain, 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Supplies, for Storage & Distribution, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Supplies, for Supply Chain Management, 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Supplies, for Pharmaceutical, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Supplies, for Biologics, 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Supplies for Medical Device, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Supplies, for Others, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Supplies, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 26 Global Clinical Trial Supplies, for CNS Diseases, 2018 - 2030 (USD Million)
  • Fig. 27 Global Clinical Trial Supplies, for Cardiovascular Diseases, 2018 - 2030 (USD Million)
  • Fig. 28 Global Clinical Trial Supplies, for Infectious Disease, 2018 - 2030 (USD Million)
  • Fig. 29 Global Clinical Trial Supplies, for Metabolic Disorders, 2018 - 2030 (USD Million)
  • Fig. 30 Global Clinical Trial Supplies, for Others, 2018 - 2030 (USD Million)
  • Fig. 31 Regional Outlook, 2024 & 2030
  • Fig. 32 North America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Japan Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 MEA Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Clinical Trial Supplies Market Estimates and Forecasts, 2018 - 2030 (USD Million)